Scoop: Bob Nelsen is build­ing a Re­al­ly Big Neu­ro­science Com­pa­ny

Over the last year, ARCH man­ag­ing di­rec­tor Bob Nelsen has been qui­et­ly rais­ing hun­dreds of mil­lions of dol­lars to launch a mas­sive neu­ro­science-fo­cused biotech.

The com­pa­ny has been fil­ing doc­u­ments out of ARCH’s San Fran­cis­co of­fice since at least May of 2020. Fit­ting­ly for Nelsen — the ven­ture cap­i­tal­ist who ini­tial­ly chris­tened the CAR-T com­pa­ny Juno “Fuck Can­cer” and the cell ther­a­py be­he­moth Sana “Fuck Dis­ease” — the biotech is op­er­at­ing un­der a co­de­name: RB­NC Ther­a­peu­tics. It stands, a source said, for Re­al­ly Big Neu­ro­science Com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER